Hormone Replacement Therapy linked to Breast Cancer

Several studies have been conducted linking combined estrogen plus progestin Hormone Replacement Therapy (HRT) to increased risk of breast cancer.  Studies performed at Stanford University School of Medicine and other Women’s Health Initiative (WHI) confirmed that combined estrogen plus progestin hormone replacement therapy (HRT) increased the risk of breast cancer.  It is proven that post-menopausal women who take these HRT for at least five years are doubling their risk of breast cancer.  WHI data also showed that women can quickly reduce their risk of breast cancer by stopping HRT.  After the 2002 report from the WHI trial linking estrogen and progestin HRT use to breast cancer, there was a dramatic drop in HRT use in the US fro 60 million prescriptions in 2001 to 20 million prescriptions in 2005.  This was followed by a reduction in rates of breast cancer detection, which suggests that stopping HRT reduced breast cancer risk.

Premarin and Prempro are manufactured by Wyeth and Provera is manufactured by Pharmacia and Upjohn.   These manufacturers failed to adequately warn both patients and doctors of the risks of these drugs on their labels.

If you, or a family member have used hormone replacement therapy and have been diagnosed with breast cancer, you may be entitled to seek and recover compensation for your losses. Please feel free to consult with one of our personal injury lawyers in New York to schedule a consultation. We will thoroughly evaluate the details of your injury to determine whether you have an eligible claim.

Please visit our website for more  cancer, information.

Related Posts